TITLE

NOVARTIS SANDOSTATIN LAR APPROVED IN JAPAN FOR ACROMEGALY

PUB. DATE
June 2004
SOURCE
Worldwide Biotech;Jun2004, Vol. 16 Issue 6, p7
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports that the Japanese Ministry of Health, Labor and Welfare has approved of Sandostatin LAR from Basel, Switzerland-based Novartis. Reasons for approving the drug; Reaction of David Epstein, president of Novartis Oncology, on the approval of Sandostatin LAR; Results of a clinical trial on the effectiveness of the drug; Mechanism of action of the drug.
ACCESSION #
13265052

 

Related Articles

  • Novartis receives Japanese approval for Gilenya and Illaris.  // PharmaWatch: CNS;Nov2011, Vol. 10 Issue 11, p4 

    The article reports on the approval received by Novartis International AG from the Ministry of Health, Labor and Welfare of Japan for the drugs Gilenya to prevent the relapse and delay of progression of physical disability in adults with multiple sclerosis (MS), and for Illaris to...

  • FDA, Japan to align devices via 'Harmonization by Doing.'.  // Medical Technology & Devices Week;3/26/2007, Vol. 5 Issue 13, p4 

    The article reports on the efforts of the U.S. Food and Drug Administration and Japan's Ministry of Health, Labor and Welfare called Harmonization by Doing (HBD), which seeks to align the medical device regulations of the two countries. Organizers of the HBD hope to develop common protocols for...

  • FDA, Japan will align devices via 'Harmonization by Doing.'. McCarty, Mark // Medical Device Daily;3/22/2007, Vol. 11 Issue 55, p1 

    The article reports that the U.S. Food and Drugs Administration (FDA) and Japan's Ministry of Health, Labour and Welfare will standardize the way medical devices come to market in the U.S. and Japan. Known as Harmonization by Doing (HBD), the effort can make it easier to get sponsors for...

  • Omega 3 Prescription Drug Approved in Japan.  // Nutraceuticals World;Nov2012, Vol. 15 Issue 9, p10 

    The article reports that the Japanese Ministry of Health, Labour and Welfare has apposed a New Drug Application (NDA) for Pronova BioPharma ASA and Takeda Pharmaceutical Co. Ltd.'s Lotigo granular capsule for the treatment of hyperlipidemia.

  • Concomitant iguratimod + warfarin contraindicated following death.  // Reactions Weekly;8/24/2013, Issue 1466, p2 

    The article reports on the recommendation of the Japan Ministry of Health, Labour & Welfare (MHLW) to stop the use of iguratimod with warfarin following the death of a patient due to pulmonary alveolar haemorrhage.

  • Pharmacovigilance & Regulatory News.  // Reactions Weekly;3/17/2007, Issue 1143, p2 

    The article reports on the issuance by the Japanese Ministry of Health, Labor and Welfare of a general warning about the need to monitor children and adolescents with flu who are receiving the oseltamivir drug called Tamiflu. The warning was issued after reports on the death of people receiving...

  • No revision to package insert precautions for clemastine.  // Reactions Weekly;May2014, Vol. 1502 Issue 1, p2 

    The article focuses on the decision of the Japanese Ministry of Health, Labour and Welfare and the Pharmaceuticals and Medical Devices Agency (PMDA) for not revising the precautions in the package of clemastine fumarate due to the misidentification of shock and anaphylaxis cases.

  • Safety updates for various drugs in Japan.  // Reactions Weekly;2/18/2006, Issue 1089, p2 

    Presents safety updates for various drugs from the Japanese Ministry of Health, Labor and Welfare. Adverse effects of amiodarone; Side effects of carboplatin; Warning on the use of sevoflurane; Change in the safety language for phenytoin preparations.

  • Cyberonics' VNS gets Japanese regulatory approval for epilepsy.  // Medical Device Daily;1/22/2010, Vol. 14 Issue 14, p1 

    The article deals with the final regulatory approval granted by the Japanese Ministry of Health, Labor & Welfare to Cyberonics in January 2010 to market and sell its vagus nerve stimulation (VNS) therapy system for the epilepsy indication. The business opportunity in Japan is described by...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics